PMN Earnings Date: Nov 11, 2026 (Estimated) — ProMIS Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is PMN's next earnings date?
ProMIS Neurosciences, Inc. (PMN) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.26.
How did PMN do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), ProMIS Neurosciences, Inc. posted EPS of -$1.28 versus the -$1.38 estimate, a beat of 29.3%. Revenue was $0. The stock's 1-day post-earnings move was +0.5%.
How much does PMN stock move after earnings?
PMN beat EPS estimates in 6 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 3.1% (up or down) in the day after earnings.
About ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, targets superoxide dismutase 1 and TAR-DNA binding protein 43 in ALS, and alpha-synuclein associated with Parkinson's disease and Lewy body dementia. Finally, PMN442 is a monoclonal antibody aimed at toxic alpha-synuclein oligomers and seeding fibrils relevant to multiple system atrophy. Established in 2004, the company changed its name from Amorfix Life Sciences Ltd. to ProMIS Neurosciences, Inc. in July 2015. Its corporate headquarters are situated in Toronto, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -1.38 | -1.28 | +29.28% | $0 | ✅ Beat | +0.47% | -0.20% | -10.34% |
| 2026-05-12 | Q1 2026 | -1.58 | -1.26 | +20.25% | $0 | ✅ Beat | -1.78% | -2.29% | -4.49% |
| 2026-03-25 | Q4 2025 | -5.71 | -3.11 | +45.53% | $0 | ✅ Beat | -9.06% | -27.14% | -37.58% |
| 2025-11-12 | Q3 2025 | -0.30 | -0.24 | +20.00% | $0 | ✅ Beat | +4.00% | -8.08% | -11.34% |
| 2025-08-13 | Q2 2025 | -0.22 | -0.29 | -31.82% | $0 | ❌ Miss | +0.00% | -19.31% | -40.29% |
| 2025-03-31 | Q4 2024 | — | -0.02 | — | $0 | — | -0.63% | -12.29% | -16.69% |
| 2024-11-14 | Q3 2024 | -0.07 | 0.31 | +542.86% | $0 | ✅ Beat | +1.47% | +1.76% | -5.10% |
| 2024-05-14 | Q1 2024 | -0.20 | -0.19 | +5.00% | $0 | ✅ Beat | -7.22% | -5.67% | -15.03% |
Showing last 8 quarters.